OptimizeRx (OPRX) Shares Repurchased (2015 - 2024)

OptimizeRx's Shares Repurchased history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2024.

• In Q4 2024, Shares Repurchased rose 510.0% year-over-year to $1.6 million; the TTM figure through Dec 2024 stood at $6.7 million (up 0.65% YoY), while the FY2024 annual figure was $6.7 million, down 14.23% from the prior year.
• Shares Repurchased came in at $1.6 million for Q4 2024 at OptimizeRx, up from $1.6 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $12.2 million in Q3 2022 to a low of $270000.0 in Q4 2023.
• A 3-year average of $3.3 million and a median of $1.7 million in 2024 frame the typical range for Shares Repurchased.
• Across the five-year window, Shares Repurchased tumbled 96.38% in 2023 and surged 510.0% in 2024, its largest moves.
• OptimizeRx's Shares Repurchased stood at $7.5 million in 2022, then sank by 96.38% to $270000.0 in 2023, then soared by 510.0% to $1.6 million in 2024.
• According to Business Quant data, Shares Repurchased over the past three periods registered $1.6 million, $1.6 million, and $1.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison